Free Webinar

Dr Mark Gooding obtained his DPhil in Medical Imaging from University of Oxford in 2004. After postdoctoral experience both in university and NHS settings, he joined Mirada Medical in 2009, motivated by a desire to see technical innovation translated into clinical practice. While there, Dr Gooding led the team developing the first AI-based contouring software for radiotherapy that was cleared for clinical use.

Recently, Dr Gooding founded Inpictura Ltd, to continue his mission to bring technical innovation to the clinic, particularly in radiation oncology. To this end, he continues to collaborate both clinically and academically.

Dr Paul Doolan is the General Coordinator of Medical Physics at the German Oncology Center in Limassol, Cyprus. He is a member of the IPEM Working Group on AI, a member of ESTRO Focus Group on AI in Radiation Oncology and a founding member of the EFOMP AI Working Party. He is a member of the EFOMP Working Group on VMAT Breast Treatments, a member of the IPEM Working Party on 3D Printing in Radiotherapy and a past Secretary of the IPEM Working Party on Online Monitoring of Radiotherapy (2019-2023). He is also a Commissioning Editor for the IPEM SCOPE members’ journal and a member of the ESTRO National Societies Committee.
After working as a Medical Physicist in the NHS in the UK, he completed a PhD in Medical Physics at University College London. He spent a year-long sabbatical at Massachusetts General Hospital and Harvard Medical School, gaining clinical experience in proton therapy and performing proton physics research. After his research experiences he returned to the clinic at University College London Hospital in the UK. He joined the German Oncology Center at the start of its operation in 2017 and assumed responsibility for the Medical Physics department as the General Coordinator in 2020.
He is passionate about improving patient care through innovation and leads his team to push forward projects in EPID-based transit dosimetry and automation in radiotherapy workflows.